Legend Biotech Corp
NASDAQ:LEGN
Legend Biotech Corp
NASDAQ:LEGN
Price:
18.21
USD
-1.83%
Market Closed
Market Cap:
$3.3B
Income Statement
Earnings Waterfall
Legend Biotech Corp
Legend Biotech Corp
Income Statement
Legend Biotech Corp
Legend Biotech Corp
Currency: USD
| Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
6
|
22
|
17
|
22
|
22
|
22
|
21
|
0
|
0
|
0
|
|
| Revenue |
60
N/A
|
61
+2%
|
63
+2%
|
57
-9%
|
75
+31%
|
77
+3%
|
86
+11%
|
91
+6%
|
69
-24%
|
105
+53%
|
97
-8%
|
48
-50%
|
110
+127%
|
206
+88%
|
285
+39%
|
343
+20%
|
456
+33%
|
520
+14%
|
627
+21%
|
728
+16%
|
797
+9%
|
909
+14%
|
1 029
+13%
|
|
| Gross Profit | ||||||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(17)
|
(53)
|
(68)
|
(112)
|
(144)
|
(163)
|
(181)
|
(192)
|
(235)
|
(250)
|
(298)
|
(359)
|
(408)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
50
N/A
|
45
-10%
|
(4)
N/A
|
41
N/A
|
94
+127%
|
141
+50%
|
179
+27%
|
275
+53%
|
327
+19%
|
393
+20%
|
477
+22%
|
498
+4%
|
550
+10%
|
621
+13%
|
|
| Operating Income | ||||||||||||||||||||||||
| Operating Expenses |
(194)
|
(227)
|
(335)
|
(366)
|
(385)
|
(420)
|
(382)
|
(407)
|
(463)
|
(485)
|
(490)
|
(239)
|
(270)
|
(415)
|
(669)
|
(615)
|
(648)
|
(679)
|
(698)
|
(716)
|
(717)
|
(741)
|
(757)
|
|
| Selling, General & Administrative |
(32)
|
(38)
|
(46)
|
(55)
|
(73)
|
(85)
|
(97)
|
(113)
|
(150)
|
(161)
|
(181)
|
(86)
|
(89)
|
(139)
|
(201)
|
(217)
|
(233)
|
(264)
|
(284)
|
(300)
|
(316)
|
(323)
|
(342)
|
|
| Research & Development |
(162)
|
(189)
|
(210)
|
(231)
|
(232)
|
(255)
|
(285)
|
(294)
|
(313)
|
(324)
|
(309)
|
(154)
|
(181)
|
(277)
|
(382)
|
(398)
|
(415)
|
(415)
|
(414)
|
(415)
|
(400)
|
(418)
|
(415)
|
|
| Other Operating Expenses |
0
|
0
|
(80)
|
(80)
|
(80)
|
(80)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(86)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
|
| Operating Income |
(134)
N/A
|
(166)
-23%
|
(273)
-64%
|
(309)
-13%
|
(310)
0%
|
(343)
-11%
|
(296)
+14%
|
(316)
-7%
|
(394)
-25%
|
(380)
+4%
|
(410)
-8%
|
(244)
+41%
|
(229)
+6%
|
(321)
-40%
|
(528)
-64%
|
(436)
+17%
|
(373)
+14%
|
(351)
+6%
|
(305)
+13%
|
(237)
+22%
|
(217)
+8%
|
(191)
+12%
|
(137)
+28%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||
| Interest Income Expense |
5
|
(3)
|
(3)
|
(3)
|
3
|
(0)
|
(2)
|
(38)
|
(6)
|
27
|
(39)
|
(53)
|
(96)
|
(102)
|
33
|
(96)
|
9
|
26
|
40
|
(34)
|
(134)
|
(141)
|
(150)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
(5)
|
(5)
|
(5)
|
0
|
|
| Total Other Income |
2
|
6
|
6
|
3
|
(1)
|
2
|
(1)
|
(3)
|
(7)
|
(5)
|
(10)
|
(9)
|
14
|
50
|
(26)
|
64
|
77
|
(20)
|
112
|
80
|
53
|
114
|
4
|
|
| Pre-Tax Income |
(127)
N/A
|
(163)
-28%
|
(269)
-65%
|
(309)
-15%
|
(308)
+0%
|
(341)
-11%
|
(299)
+13%
|
(356)
-19%
|
(407)
-14%
|
(358)
+12%
|
(459)
-28%
|
(305)
+34%
|
(311)
-2%
|
(373)
-20%
|
(520)
-39%
|
(468)
+10%
|
(287)
+39%
|
(346)
-20%
|
(158)
+54%
|
(197)
-25%
|
(304)
-54%
|
(222)
+27%
|
(283)
-27%
|
|
| Net Income | ||||||||||||||||||||||||
| Tax Provision |
26
|
29
|
30
|
30
|
42
|
38
|
38
|
38
|
4
|
3
|
3
|
(0)
|
(0)
|
(0)
|
2
|
2
|
2
|
(3)
|
(19)
|
(20)
|
(21)
|
(17)
|
(14)
|
|
| Income from Continuing Operations |
(102)
|
(133)
|
(239)
|
(278)
|
(266)
|
(303)
|
(260)
|
(319)
|
(404)
|
(355)
|
(456)
|
(305)
|
(311)
|
(373)
|
(518)
|
(466)
|
(285)
|
(348)
|
(177)
|
(218)
|
(325)
|
(240)
|
(297)
|
|
| Net Income (Common) |
(102)
N/A
|
(133)
-31%
|
(239)
-80%
|
(278)
-16%
|
(266)
+4%
|
(303)
-14%
|
(260)
+14%
|
(319)
-22%
|
(404)
-27%
|
(355)
+12%
|
(456)
-28%
|
(305)
+33%
|
(311)
-2%
|
(373)
-20%
|
(518)
-39%
|
(466)
+10%
|
(285)
+39%
|
(348)
-22%
|
(177)
+49%
|
(218)
-23%
|
(325)
-49%
|
(240)
+26%
|
(297)
-24%
|
|
| EPS (Diluted) |
-0.51
N/A
|
-0.51
N/A
|
-0.92
-80%
|
-1.05
-14%
|
-1.13
-8%
|
-1.15
-2%
|
-0.85
+26%
|
-1.09
-28%
|
-1.43
-31%
|
-1.14
+20%
|
-1.47
-29%
|
-0.92
+37%
|
-0.88
+4%
|
-1.02
-16%
|
-1.47
-44%
|
-1.28
+13%
|
-0.78
+39%
|
-0.95
-22%
|
-0.48
+49%
|
-0.59
-23%
|
-0.89
-51%
|
-0.65
+27%
|
-0.81
-25%
|
|
Switch to:
Switch to:
See Also
Discover More
